WILLIAM IRBY: Open Payments
NPI 1902874779 · HAMILTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 33 payments from 12 companies in 2025. Trend: 2023 $1,053 · 2024 $1,040 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $133 |
| Vanda Pharmaceuticals Inc. | 6 | $110 |
| Amgen Inc. | 6 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Lilly USA, LLC | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| ABBVIE INC. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: Dexcom G6 Transmitter, FANAPT, OTEZLA, REXULTI, MOUNJARO, BREZTRI, JARDIANCE, CREON.
Industry payments across MO — which companies pay providers there.
